IP Verse

Use Of Chimeric Antigen Receptor Modified T Cells To Treat Cancer - EP3214091

PATENT ANALYSIS

Patent Details

Grant Date
Oct 3, 2018
Company
THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
Oppositions

MEDECINS DU MONDE ET AL

MILTENYI BIOTEC GMBH

PLASSERAUD IP

PUBLIC EYE

More patents of The Trustees Of The University Of Pennsylvania

EP2496182

EP3250681

EP4019041

Want to monitor this patent?

Feel free to send us a message here and we will get back to you